Loring Wolcott & Coolidge Fiduciary Advisors’s Radius Health, Inc. RDUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-10
| Closed | – | – | 652 |
|
|
2022
Q2 | $0 | Hold |
10
| – | – | ﹤0.01% | 693 |
|
|
2022
Q1 | $0 | Hold |
10
| – | – | ﹤0.01% | 735 |
|
|
2021
Q4 | $0 | Hold |
10
| – | – | ﹤0.01% | 782 |
|
|
2021
Q3 | $0 | Hold |
10
| – | – | ﹤0.01% | 963 |
|
|
2021
Q2 | $0 | Buy |
+10
| New | +$199 | ﹤0.01% | 956 |
|
|
2021
Q1 | – | Sell |
-10
| Closed | – | – | 752 |
|
|
2020
Q4 | $0 | Hold |
10
| – | – | ﹤0.01% | 804 |
|
|
2020
Q3 | $0 | Hold |
10
| – | – | ﹤0.01% | 619 |
|
|
2020
Q2 | $0 | Hold |
10
| – | – | ﹤0.01% | 669 |
|
|
2020
Q1 | $0 | Hold |
10
| – | – | ﹤0.01% | 723 |
|
|
2019
Q4 | $0 | Hold |
10
| – | – | ﹤0.01% | 733 |
|
|
2019
Q3 | $0 | Hold |
10
| – | – | ﹤0.01% | 749 |
|
|
2019
Q2 | $0 | Hold |
10
| – | – | ﹤0.01% | 778 |
|
|
2019
Q1 | $0 | Hold |
10
| – | – | ﹤0.01% | 779 |
|
|
2018
Q4 | $0 | Hold |
10
| – | – | ﹤0.01% | 736 |
|
|
2018
Q3 | $0 | Hold |
10
| – | – | ﹤0.01% | 686 |
|
|
2018
Q2 | $0 | Hold |
10
| – | – | ﹤0.01% | 744 |
|
|
2018
Q1 | $0 | Hold |
10
| – | – | ﹤0.01% | 802 |
|
|
2017
Q4 | $0 | Hold |
10
| – | – | ﹤0.01% | 902 |
|
|
2017
Q3 | $0 | Hold |
10
| – | – | ﹤0.01% | 928 |
|
|
2017
Q2 | $0 | Hold |
10
| – | – | ﹤0.01% | 665 |
|
|
2017
Q1 | $0 | Hold |
10
| – | – | ﹤0.01% | 632 |
|
|
2016
Q4 | $0 | Buy |
+10
| New | +$476 | ﹤0.01% | 624 |
|
Other funds holding RDUS
Loring Wolcott & Coolidge Fiduciary Advisors's RDUS Position: Q3 2022 in Review
Loring Wolcott & Coolidge Fiduciary Advisors sold out of Radius Health, Inc. (RDUS) in Q3 2022, closing a stake of 10 shares.
Loring Wolcott & Coolidge Fiduciary Advisors first reported a position in RDUS in Q4 2016 and held it in 22 quarters. The position peaked at $0 in Q2 2022. 1 fund tracked by Wall St. Rank holds RDUS as of Q3 2022.
- Loring Wolcott & Coolidge Fiduciary Advisors reported no remaining Radius Health, Inc. position as of Q3 2022 after selling out during the quarter.
- Loring Wolcott & Coolidge Fiduciary Advisors sold 10 Radius Health, Inc. shares in Q3 2022.
- Loring Wolcott & Coolidge Fiduciary Advisors first reported a position in Radius Health, Inc. in Q4 2016 and held it in 22 quarters.
- Loring Wolcott & Coolidge Fiduciary Advisors's Radius Health, Inc. position peaked at $0 in Q2 2022.
- 1 fund tracked by Wall St. Rank held Radius Health, Inc. as of Q3 2022.
Based on Loring Wolcott & Coolidge Fiduciary Advisors's 13F filing for Q3 2022, filed 25 Oct 2022.